| Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells J Lee, MJ Son, K Woolard, NM Donin, A Li, CH Cheng, S Kotliarova, ... Cancer cell 13 (1), 69-80, 2008 | 543 | 2008 |
| Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers F Zhang, NN Parayath, CI Ene, SB Stephan, AL Koehne, ME Coon, ... Nature communications 10 (1), 3974, 2019 | 440 | 2019 |
| Effect of brain-and tumor-derived connective tissue growth factor on glioma invasion LA Edwards, K Woolard, MJ Son, A Li, J Lee, C Ene, SA Mantey, D Maric, ... Journal of the National Cancer Institute 103 (15), 1162-1178, 2011 | 150 | 2011 |
| Timing of cranioplasty: a 10.75-year single-center analysis of 754 patients RP Morton, IJ Abecassis, JF Hanson, JK Barber, M Chen, CM Kelly, ... Journal of neurosurgery 128 (6), 1648-1652, 2017 | 143 | 2017 |
| Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization CI Ene, L Edwards, G Riddick, M Baysan, K Woolard, S Kotliarova, C Lai, ... PloS one 7 (12), e51407, 2012 | 139 | 2012 |
| Nanoparticles that reshape the tumor milieu create a therapeutic window for effective T-cell therapy in solid malignancies F Zhang, SB Stephan, CI Ene, TT Smith, EC Holland, MT Stephan Cancer research 78 (13), 3718-3730, 2018 | 129 | 2018 |
| Predictors of infection after 754 cranioplasty operations and the value of intraoperative cultures for cryopreserved bone flaps RP Morton, IJ Abecassis, JF Hanson, J Barber, JD Nerva, SN Emerson, ... Journal of neurosurgery 125 (3), 766-770, 2016 | 92 | 2016 |
| Natural history of cerebral cavernous malformations C Ene, A Kaul, L Kim Handbook of clinical neurology 143, 227-232, 2017 | 67 | 2017 |
| Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses KJ Brempelis, CM Cowan, SA Kreuser, KP Labadie, BM Prieskorn, ... Journal for immunotherapy of cancer 8 (2), e001356, 2020 | 62 | 2020 |
| Many tumors in one: a daunting therapeutic prospect CI Ene, HA Fine Cancer cell 20 (6), 695-697, 2011 | 59 | 2011 |
| Personalized medicine for gliomas CI Ene, EC Holland Surgical neurology international 6 (Suppl 1), S89, 2015 | 57 | 2015 |
| Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma CI Ene, SA Kreuser, M Jung, H Zhang, S Arora, K White Moyes, ... Neuro-oncology 22 (5), 639-651, 2020 | 53 | 2020 |
| Desmoplastic infantile ganglioglioma/astrocytoma (DIG/DIA) are distinct entities with frequent BRAFV600 mutations AC Wang, DTW Jones, IJ Abecassis, BL Cole, SES Leary, CM Lockwood, ... Molecular cancer research 16 (10), 1491-1498, 2018 | 47 | 2018 |
| Mitotic index thresholds do not predict clinical outcome for IDH-mutant astrocytoma RA Yoda, T Marxen, L Longo, C Ene, HG Wirsching, CD Keene, ... Journal of Neuropathology & Experimental Neurology 78 (11), 1002-1010, 2019 | 44 | 2019 |
| Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors SR Chen, MM Chen, C Ene, FF Lang, P Kan Journal of neurointerventional surgery 14 (6), 533-538, 2022 | 40 | 2022 |
| Surgical management of brain metastasis: challenges and nuances CI Ene, SD Ferguson Frontiers in oncology 12, 847110, 2022 | 39 | 2022 |
| Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma HG Wirsching, H Zhang, F Szulzewsky, S Arora, P Grandi, PJ Cimino, ... JCI insight 4 (13), e128217, 2019 | 29 | 2019 |
| An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma E Hasanov, DN Yeboa, MD Tucker, TA Swanson, TH Beckham, B Rini, ... CA: A Cancer Journal for Clinicians 72 (5), 454-489, 2022 | 24 | 2022 |
| Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors CI Ene, JD Nerva, RP Morton, AS Barkley, JK Barber, AL Ko, ... Surgical Neurology International 7 (Suppl 11), S295, 2016 | 21 | 2016 |
| Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations CI Ene, J Fueyo, FF Lang Neurosurgical focus 50 (2), E6, 2021 | 20 | 2021 |
Eric HollandFred Hutchinson Cancer Research CenterVerified email at fredhutch.org